These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15313419)
1. Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy. Varier RA; Swaminathan V; Balasubramanyam K; Kundu TK Biochem Pharmacol; 2004 Sep; 68(6):1215-20. PubMed ID: 15313419 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation by the acetylation of nonhistone proteins in humans -- a new target for therapeutics. Das C; Kundu TK IUBMB Life; 2005 Mar; 57(3):137-49. PubMed ID: 16036576 [TBL] [Abstract][Full Text] [Related]
3. Histone acetyl transferases as emerging drug targets. Dekker FJ; Haisma HJ Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000 [TBL] [Abstract][Full Text] [Related]
4. Small molecule modulators in epigenetics: implications in gene expression and therapeutics. Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138 [TBL] [Abstract][Full Text] [Related]
5. High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate). Turlais F; Hardcastle A; Rowlands M; Newbatt Y; Bannister A; Kouzarides T; Workman P; Aherne GW Anal Biochem; 2001 Nov; 298(1):62-8. PubMed ID: 11673896 [TBL] [Abstract][Full Text] [Related]
6. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Selvi RB; Kundu TK Biotechnol J; 2009 Mar; 4(3):375-90. PubMed ID: 19296442 [TBL] [Abstract][Full Text] [Related]
7. Histone acetylation in gene regulation. Verdone L; Agricola E; Caserta M; Di Mauro E Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467 [TBL] [Abstract][Full Text] [Related]
8. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Hodawadekar SC; Marmorstein R Oncogene; 2007 Aug; 26(37):5528-40. PubMed ID: 17694092 [TBL] [Abstract][Full Text] [Related]
9. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies. Quivy V; De Walque S; Van Lint C Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137 [TBL] [Abstract][Full Text] [Related]
10. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools. Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132 [TBL] [Abstract][Full Text] [Related]
11. Role of histone acetylation in the control of gene expression. Verdone L; Caserta M; Di Mauro E Biochem Cell Biol; 2005 Jun; 83(3):344-53. PubMed ID: 15959560 [TBL] [Abstract][Full Text] [Related]
14. Assays for the identification and evaluation of histone acetyltransferase inhibitors. Wynne Aherne G; Rowlands MG; Stimson L; Workman P Methods; 2002 Mar; 26(3):245-53. PubMed ID: 12054880 [TBL] [Abstract][Full Text] [Related]
15. Role of histone and transcription factor acetylation in diabetes pathogenesis. Gray SG; De Meyts P Diabetes Metab Res Rev; 2005; 21(5):416-33. PubMed ID: 15906405 [TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates. Furdas SD; Kannan S; Sippl W; Jung M Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of airway inflammation. Adcock IM; Tsaprouni L; Bhavsar P; Ito K Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468 [TBL] [Abstract][Full Text] [Related]
19. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A; Altucci L Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076 [TBL] [Abstract][Full Text] [Related]